Camp4 Therapeutics (CAMP) Capital Leases (2023 - 2025)

Camp4 Therapeutics' Capital Leases history runs 3 years deep, the most recent figure standing at $47000.0 for Q3 2025.

• In Q3 2025, Capital Leases fell 45.98% year-over-year to $47000.0; the TTM figure through Sep 2025 stood at $47000.0 (down 45.98% YoY), while the FY2024 annual figure was $70000.0, down 52.7% from the prior year.
• Capital Leases came in at $47000.0 for Q3 2025 at Camp4 Therapeutics, down from $59000.0 in the prior quarter.
• In the past five years, Capital Leases ranged from a high of $148000.0 in Q4 2023 to a low of $47000.0 in Q3 2025.
• A 3-year average of $78166.7 and a median of $64500.0 in 2024 frame the typical range for Capital Leases.
• Across the five-year window, Capital Leases plunged 52.7% in 2024 and slumped 45.98% in 2025, its largest moves.
• Camp4 Therapeutics' Capital Leases stood at $148000.0 in 2023, then slumped by 52.7% to $70000.0 in 2024, then tumbled by 32.86% to $47000.0 in 2025.
• According to Business Quant data, Capital Leases over the past three periods registered $47000.0, $59000.0, and $58000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.

Peer Comparison